Stay updated on Radiotherapy, Chemo, Nivolumab for HPV-HN Cancer Clinical Trial

Sign up to get notified when there's something new on the Radiotherapy, Chemo, Nivolumab for HPV-HN Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Radiotherapy, Chemo, Nivolumab for HPV-HN Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision updated from v3.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T13:40:51.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T21:14:35.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3. This appears to be a maintenance update and does not modify the study details or user-facing information.
    Difference
    0.1%
    Check dated 2026-03-12T19:29:12.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed Revision: v3.4.1. This appears to be an internal versioning update with no impact on study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-02-12T00:01:43.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1; this is a minor update and does not affect content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:34:38.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Results have been posted for progression-free survival (PFS), overall survival (OS), and toxicity outcomes with a 2-year follow-up. Additional results include the correlation of mid-treatment FDG-PET scans with post-treatment PET-CT and the percentage decrease of MTV2.5 from baseline, along with linked PDFs for the Informed Consent Form and the Study Protocol and statistical analysis plan (SAP).
    Difference
    2%
    Check dated 2026-01-28T19:50:04.000Z thumbnail image

Stay in the know with updates to Radiotherapy, Chemo, Nivolumab for HPV-HN Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Radiotherapy, Chemo, Nivolumab for HPV-HN Cancer Clinical Trial page.